NRx Pharma (NRXP): מחיר למכירות

סמל מסחרי של NRx Pharmaceuticals, Inc (NRXP)

NRx Pharmaceuticals is advancing psychopharmacology through partnerships with mental health centers, accelerating the patenting of software. The P/S ratio history reflects market valuation dynamics, where the current value is 27.80. However, test volatility and financial instability create risks. Simultaneously, NRx Pharmaceuticals is implementing software robots to digitize medical records to accelerate the time-to-market for its drugs.

NRXP (nrxpharma.com) היסטוריית יחס מחיר להכנסות מ-16.11.2025 עד 15.11.2026

NRx Pharmaceuticals (NRXP) - פילוחי מדדים ודוחות פיננסיים

- מחיר מניה וקונצנזוס הערכת שווי:
ניתוח פונדמנטלי של החברה:NRx Pharmaceuticals, Inc. - NRXP
מוצרים מיוצרים של NRx Pharmaceuticals, Inc

NRx Pharmaceuticals focuses on developing innovative therapies for severe depressive states. The P/S ratio measures market capitalization relative to annual sales volume, determining the cost of one dollar of revenue. This metric allows an investor to assess the efficiency of the company's monetization of clinical successes compared to industry peers. Analyzing the revenue multiple helps identify deviations of the asset's current value from its historical norms.